Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
2.910
-0.250 (-7.91%)
At close: Jan 23, 2026, 4:00 PM EST
2.930
+0.020 (0.69%)
After-hours: Jan 23, 2026, 7:58 PM EST
Absci Market Cap
Absci has a market cap or net worth of $437.58 million as of January 23, 2026. Its market cap has increased by 24.10% in one year.
Market Cap
437.58M
Enterprise Value
291.33M
1-Year Change
24.10%
Ranking
Category
Stock Price
$2.91
Market Cap Chart
Since the IPO on July 22, 2021, Absci's market cap has increased from $423.19M to $437.58M, an increase of 3.40%. That is a compound annual growth rate of 0.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 437.58M | -16.62% |
| Dec 31, 2025 | 524.80M | 74.40% |
| Dec 31, 2024 | 300.92M | -22.91% |
| Dec 29, 2023 | 390.34M | 101.18% |
| Dec 30, 2022 | 194.03M | -74.44% |
| Dec 31, 2021 | 759.25M | 79.41% |
| Jul 22, 2021 | 423.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immutep | 465.73M |
| DiaMedica Therapeutics | 455.95M |
| Eupraxia Pharmaceuticals | 455.47M |
| 4D Molecular Therapeutics | 454.80M |
| NovaBridge Biosciences | 448.48M |
| ADC Therapeutics | 447.20M |
| Assembly Biosciences | 443.04M |
| PureTech Health | 441.58M |